Michaela Ott
Direktor/Vorstandsmitglied bei Medite Enterprise, Inc.
Aktive Positionen von Michaela Ott
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Medite Enterprise, Inc.
Medite Enterprise, Inc. Medical SpecialtiesHealth Technology Part of MEDITE Cancer Diagnostics, Inc., Medite Enterprise, Inc. develops diagnostics and therapeutic medical devices. The company is based in Orlando, FL. Michael Egbert Ott has been the CEO of the company since 2013. Medite Enterprise was acquired by CytoCore, Inc. on April 04, 2014 for $342 million. | Direktor/Vorstandsmitglied | 01.01.2013 | - |
Karriereverlauf von Michaela Ott
Ehemalige bekannte Positionen von Michaela Ott
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MEDITE CANCER DIAGNOSTICS INC | Direktor/Vorstandsmitglied | 03.04.2014 | 17.01.2018 |
Vorstandsvorsitzender | 03.04.2014 | 26.10.2016 | |
Geschäftsführer | 26.10.2016 | 04.05.2017 | |
Medite GmbH /Austria/
Medite GmbH /Austria/ Medical SpecialtiesHealth Technology Part of MEDITE Cancer Diagnostics, Inc., Medite GmbH is a company based in Salzburg, Austria. Medite GmbH develops diagnostics and therapeutic medical devices. | Vorstandsvorsitzender | - | 30.09.2017 |
MEDITE GmbH
MEDITE GmbH Medical DistributorsDistribution Services Part of MEDITE Cancer Diagnostics, Inc., Medite GmbH is a German company that develops diagnostics and therapeutic medical devices. The company is based in Niedersachsen, Germany. The CEO of the company is Elmar A. Dave. | Präsident | 01.01.2006 | 04.05.2017 |
CytoCore, Inc.
CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | Vorstandsvorsitzender | 03.04.2014 | - |
Statistik
International
Vereinigte Staaten | 4 |
Deutschland | 2 |
Österreich | 2 |
Operativ
Chief Executive Officer | 3 |
Director/Board Member | 2 |
President | 1 |
Sektoral
Health Technology | 5 |
Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MEDITE CANCER DIAGNOSTICS INC | Health Technology |
Private Unternehmen | 4 |
---|---|
CytoCore, Inc.
CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | Health Technology |
MEDITE GmbH
MEDITE GmbH Medical DistributorsDistribution Services Part of MEDITE Cancer Diagnostics, Inc., Medite GmbH is a German company that develops diagnostics and therapeutic medical devices. The company is based in Niedersachsen, Germany. The CEO of the company is Elmar A. Dave. | Distribution Services |
Medite Enterprise, Inc.
Medite Enterprise, Inc. Medical SpecialtiesHealth Technology Part of MEDITE Cancer Diagnostics, Inc., Medite Enterprise, Inc. develops diagnostics and therapeutic medical devices. The company is based in Orlando, FL. Michael Egbert Ott has been the CEO of the company since 2013. Medite Enterprise was acquired by CytoCore, Inc. on April 04, 2014 for $342 million. | Health Technology |
Medite GmbH /Austria/
Medite GmbH /Austria/ Medical SpecialtiesHealth Technology Part of MEDITE Cancer Diagnostics, Inc., Medite GmbH is a company based in Salzburg, Austria. Medite GmbH develops diagnostics and therapeutic medical devices. | Health Technology |
- Börse
- Insiders
- Michaela Ott
- Erfahrung